Print Page  Close Window


SEC Filings

8-K
OREXIGEN THERAPEUTICS, INC. filed this Form 8-K on 07/05/2018
Entire Document
 


Case 18-10518-KG    Doc 446    Filed 06/29/18    Page 7 of 11

 

In re: Orexigen Therapeutics, Inc.    Case No. 18-10518 (KG)
Debtor    Reporting Period: May 1, 2018 - May 31, 2018

 

MOR - 1c

Schedule of Professional Fees and Expenses Paid

For the Period: May 1, 2018 - May 31, 2018

(Unaudited)

 

                        Month Ended
5/31/18
    Cumulative Since Filing  

Payee

 

Category

 

Payor

  Date     Period Covered     Fees     Expenses     Fees     Expenses  

Retained Professionals

               

Perella Weinberg Partners1

  Debtor Investment Banker   Orexigen Therapeutics, Inc.           $ 437,500       1,738  

Other Restructuring Professionals

               

Wilmington Trust, National Association

  DIP Administrative Agent   Orexigen Therapeutics, Inc.           $ 50,000       —    

Arnold & Porter Kaye Scholer LLP

  DIP Administrative Agent Counsel   Orexigen Therapeutics, Inc.             60,650       —    

Quinn Emanuel Urquhart & Sullivan, LLP

  DIP Lenders Counsel   Orexigen Therapeutics, Inc.             172,846       236  

Brown Rudnick LLP

  DIP Lender Counsel   Orexigen Therapeutics, Inc.     5/11/2018       3/1/2018 - 3/31/2018     $ 25,333     $ 786       134,881       1,497  

Whiteford Taylor Preston

  DIP Lenders Local Counsel   Orexigen Therapeutics, Inc.     5/18/2018       3/1/2018 - 3/31/2018       75,959       1,243       129,090    
        5/29/2018       4/1/2018 - 4/30/2018             1,383  
         

 

 

   

 

 

   

 

 

   

 

 

 

Total

          $  101,292     $ 2,029     $ 984,966     $ 4,855  

Notes:

 

(1) The 4/18/2018 Perella Weinberg Partners payment was a clerical error and paid prior to the filing of a fee application. The amount paid will be offset against future fee applications filed.